Latest Commercial Sales News

Syrah Resources has resumed production at its Balama graphite mine after a year-long halt and is advancing sales at its US Vidalia anode material facility, supported by new US tariffs on Chinese imports and a $70 million equity raise.

Syrah Resources has launched a fully underwritten A$70 million equity raising to support its Balama graphite operations and Vidalia Active Anode Material facility, alongside securing a two-year forbearance on its US Department of Energy loan. The company advances commercial qualification of Vidalia AAM amid strong demand and US tariff support.

Syrah Resources has launched a A$70 million equity raising and secured a two-year forbearance on its US Department of Energy loan, bolstering its cash position and operational flexibility amid ongoing challenges.

Argosy Minerals has made significant strides in developing its Rincon Lithium Project in Argentina, securing a 40MW energy infrastructure agreement and completing a $2 million placement to fund ongoing feasibility and engineering works.

Alpha HPA Limited has kicked off major civil works for its HPA First Project Stage 2 while securing strong sales momentum in the semiconductor sector, supported by expanded Letters of Intent covering over 60% of Stage 2 capacity.

Viva Energy has reported a stronger-than-expected first half EBITDA, buoyed by operational efficiencies and refinery margins, even as convenience sales face headwinds from tobacco regulation.

Australian Strategic Materials (ASM) reports significant progress in Q2 2025, including its first commercial heavy rare earth metals sale and a transformative low-cost production pathway at its Dubbo Project.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Argosy Minerals has executed a spot sales contract for 60 tonnes of high-purity lithium carbonate from its Rincon project, marking a significant step in its lithium market engagement.

Paradigm Biopharmaceuticals has acquired Proteobioactives, securing global rights to an oral combination therapy targeting early-stage osteoarthritis in humans and animals, complementing its injectable PPS phase 3 program.

Green Critical Minerals has raised A$7 million through an institutional placement to accelerate the commercial rollout of its Very High Density graphite technology, aiming for first revenue in early 2026.